AstraZeneca PLC is 217.3x more valuable than Bicara Therapeutics Inc. by market capitalization ($286.27 B vs $1.32 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCAX | AZN |
|---|---|---|
| Market cap | $1.32 B | $286.27 B |
| US-listed rank | #2432 | #45 |
| Net income (latest FY) | -$137.95M | - |
| SEC filings | 221 | 1,004 |
AstraZeneca PLC is 217.3x more valuable than Bicara Therapeutics Inc. by market capitalization ($286.27 B vs $1.32 B).
Full pages: Bicara Therapeutics Inc. and AstraZeneca PLC, or browse the full rankings.